New Phase 3b Interim Data from STARDUST Study Show Two-Thirds of Patients with Moderately to Severely Active Crohn's Disease Achieved Clinical Remission After Two Doses of STELARA® (ustekinumab) | Business Wire
TARGET-IBD Poster & Oral Presentation at ECCO
PDF) ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
PPT - A Report from ECCO 14 Oral Chemotherapy in Colorectal Cancer PowerPoint Presentation - ID:3575065
Conference Highlights - ECCO 2020: subcutaneous-vedolizumab-maintenance-therapy-in-cd
Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis - Allen - 2017 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
PDF) Identification of Chitinase-3-Like Protein 1 as a Novel Neutrophil Antigenic Target in Crohn's Disease
Review: THE TARGET by David Baldacci (Macmillan/Grand Central) | Civilian Reader
PDF) ECCO2R therapy in the ICU: consensus of a European round table meeting
PDF) Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review
Value Chain Analysis
TARGET-IBD Poster & Oral Presentation at ECCO
Treat to Target: A Proposed New Paradigm for the Management of Crohn's Disease - Clinical Gastroenterology and Hepatology
Plus Therapeutics, Inc. Free Writing Prospectus FWP
PDF) ECCO Position Paper: Harmonization of the Approach to Ulcerative Colitis Histopathology
ECCO Portal
RNAO - ECCO MODEL 3.0
Treat-to-Target Approach in Inflammatory Bowel Disease: The Role of Advanced Practice Providers - ScienceDirect
Acceptability of a 'treat to target' approach in inflammatory bowel disease to patients in clinical remission | Frontline Gastroenterology
Geox case analysis
Ecco perché migliora il saldo italiano Target 2 | The Walking Debt
Treat-to-Target in Pediatric Inflammatory Bowel Disease: What Does the Evidence Say? | SpringerLink
Novel Analgesics with Peripheral Targets | SpringerLink
